| Q37983012 | A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy |
| Q53566583 | Abnormal function and glucose metabolism in the type-2 diabetic db/db mouse heart. |
| Q54525101 | Activation of CaMKII as a key regulator of reactive oxygen species production in diabetic rat heart. |
| Q37234352 | Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability. |
| Q39897078 | Alterations in sarcoplasmic reticulum and mitochondrial functions in diabetic cardiomyopathy |
| Q98291812 | Associated Targets of the Antioxidant Cardioprotection of Ganoderma lucidum in Diabetic Cardiomyopathy by Using Open Targets Platform: A Systematic Review |
| Q55049902 | Calcium Signaling in the Ventricular Myocardium of the Goto-Kakizaki Type 2 Diabetic Rat. |
| Q44917782 | Calcium homeostasis in vascular smooth muscle cells is altered in type 2 diabetes by Bcl-2 protein modulation of InsP3R calcium release channels |
| Q90096377 | Carbonic anhydrase II/sodium-proton exchanger 1 metabolon complex in cardiomyopathy of ob-/- type 2 diabetic mice |
| Q36174773 | Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus. |
| Q33820434 | Cardiac Ion Channel Regulation in Obesity and the Metabolic Syndrome: Relevance to Long QT Syndrome and Atrial Fibrillation |
| Q37018537 | Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice |
| Q35026344 | Cardioprotection by controlling hyperamylinemia in a "humanized" diabetic rat model |
| Q102053976 | Cardioprotective effects of short-term empagliflozin treatment in db/db mice |
| Q90321777 | Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes |
| Q43138069 | Characterization of L-type calcium channel activity in atrioventricular nodal myocytes from rats with streptozotocin-induced Diabetes mellitus |
| Q88235163 | Computational modeling of amylin-induced calcium dysregulation in rat ventricular cardiomyocytes |
| Q92852811 | Contribution of Impaired Insulin Signaling to the Pathogenesis of Diabetic Cardiomyopathy |
| Q38304968 | Control of cardiac repolarization by phosphoinositide 3-kinase signaling to ion channels |
| Q33634756 | Criteria for creating and assessing mouse models of diabetic neuropathy |
| Q44832895 | Decreased L-type calcium current in antral smooth muscle cells of STZ-induced diabetic rats |
| Q34271053 | Diabetes alters intracellular calcium transients in cardiac endothelial cells |
| Q93025434 | Diabetic Cardiomyopathy |
| Q57808947 | Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging Models |
| Q37832957 | Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets |
| Q26799318 | Diabetic Cardiomyopathy; Summary of 41 Years |
| Q57186141 | Diabetic cardiomyopathy |
| Q26997062 | Diabetic cardiomyopathy: bench to bedside |
| Q30457504 | Diabetic cardiomyopathy: pathophysiology and clinical features |
| Q28395852 | Diabetic cardiomyopathy: signaling defects and therapeutic approaches |
| Q28683010 | Diabetic db/db mice exhibit central nervous system and peripheral molecular alterations as seen in neurological disorders |
| Q24306819 | Dominant negative suppression of Rad leads to QT prolongation and causes ventricular arrhythmias via modulation of L-type Ca2+ channels in the heart |
| Q58770641 | Dysregulation of the calcium handling protein, CCDC47, is associated with diabetic cardiomyopathy |
| Q28584017 | Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats |
| Q37663364 | Effect of isoflurane on myocardial energetic and oxidative stress in cardiac muscle from Zucker diabetic fatty rat. |
| Q64076654 | Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats |
| Q27016164 | Endoplasmic reticulum stress and diabetic cardiomyopathy |
| Q46725830 | Endoplasmic reticulum stress is involved in myocardial apoptosis of streptozocin-induced diabetic rats |
| Q37858336 | Endoplasmic-reticulum calcium depletion and disease |
| Q98613606 | Established and Emerging Mechanisms of Diabetic Cardiomyopathy |
| Q35850796 | Exacerbation of acidosis during ischemia and reperfusion arrhythmia in hearts from type 2 Diabetic Otsuka Long-Evans Tokushima Fatty rats |
| Q37233149 | Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation |
| Q28080067 | Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy |
| Q36410776 | GSH or palmitate preserves mitochondrial energetic/redox balance, preventing mechanical dysfunction in metabolically challenged myocytes/hearts from type 2 diabetic mice |
| Q64241226 | Gender-Dependent Alteration of Ca and TNFα Signaling in / Mice, an Obesity-Linked Type 2 Diabetic Model |
| Q46063099 | Heart failure in diabetes |
| Q28388331 | Hearts from mice fed a non-obesogenic high-fat diet exhibit changes in their oxidative state, calcium and mitochondria in parallel with increased susceptibility to reperfusion injury |
| Q28533775 | Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy |
| Q37014942 | High- and moderate-intensity training normalizes ventricular function and mechanoenergetics in mice with diet-induced obesity |
| Q40982837 | High-Intensity Exercise Reduces Cardiac Fibrosis and Hypertrophy but Does Not Restore the Nitroso-Redox Imbalance in Diabetic Cardiomyopathy |
| Q35829973 | Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats |
| Q49384661 | Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart. |
| Q28276371 | Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart |
| Q64079051 | Impaired Activity of Ryanodine Receptors Contributes to Calcium Mishandling in Cardiomyocytes of Metabolic Syndrome Rats |
| Q46087978 | Increased O2 cost of basal metabolism and excitation-contraction coupling in hearts from type 2 diabetic mice |
| Q37333469 | Increased persistent sodium current due to decreased PI3K signaling contributes to QT prolongation in the diabetic heart |
| Q34981029 | Increased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosis |
| Q39232024 | Inflammation and metabolic cardiomyopathy |
| Q55399483 | Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats. |
| Q37278004 | Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy |
| Q30496528 | Involvement of endoplasmic reticulum stress in myocardial apoptosis of streptozocin-induced diabetic rats |
| Q37574291 | L-type Ca(2+) current in ventricular cardiomyocytes. |
| Q54587769 | Lasting alterations of the sodium current by short-term hyperlipidemia as a mechanism for initiation of cardiac remodeling. |
| Q37324188 | Loss of cardiac phosphoinositide 3-kinase p110 alpha results in contractile dysfunction |
| Q58595523 | Lower sarcoplasmic reticulum Ca threshold for triggering afterdepolarizations in diabetic rat hearts |
| Q51775769 | Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. |
| Q37583506 | Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression. |
| Q36699924 | Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes |
| Q36930481 | Metabolic dysfunction in diabetic cardiomyopathy |
| Q33635345 | Mir30c Is Involved in Diabetic Cardiomyopathy through Regulation of Cardiac Autophagy via BECN1 |
| Q89878208 | Mitochondrial Mechanisms in Diabetic Cardiomyopathy |
| Q35057592 | Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. |
| Q37672583 | Molecular mechanisms of diabetic cardiomyopathy. |
| Q30897135 | Morphological characteristics of cardiac calcium release units in animals with metabolic and circulatory disorders |
| Q46034115 | Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection. |
| Q38984265 | NOD1 receptor is up-regulated in diabetic human and murine myocardium. |
| Q42736763 | Neurobehavioral deficits in db/db diabetic mice |
| Q37698313 | O-GlcNAcylation, an original modulator of contractile activity in striated muscle |
| Q37040657 | O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function |
| Q59800367 | Of mice and men: models and mechanisms of diabetic cardiomyopathy |
| Q51411010 | Ovariectomy enhances SR Ca²⁺ release and increases Ca²⁺ spark amplitudes in isolated ventricular myocytes. |
| Q38312881 | Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome. |
| Q36312752 | Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats |
| Q91049823 | Physiological assessment of high glucose neurotoxicity in mouse and rat retinal explants |
| Q33806055 | Prevalence of QT prolongation and associated LVEF changes in diabetic patients over a four-year retrospective time period |
| Q58693859 | Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity |
| Q89997608 | Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity |
| Q26849625 | Reactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heart |
| Q36102219 | Reconciling depressed Ca2+ sparks occurrence with enhanced RyR2 activity in failing mice cardiomyocytes. |
| Q36714022 | Reduction in Kv Current Enhances the Temporal Dispersion of the Action Potential in Diabetic Myocytes: Insights From a Novel Repolarization Algorithm |
| Q36738639 | Restoration of defective L-type Ca2+ current in cardiac myocytes of type 2 diabetic db/db mice by Akt and PKC-ι |
| Q33727613 | Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy |
| Q97520963 | Role of Leptin in Cardiovascular Diseases |
| Q37661395 | Role of ryanodine receptor subtypes in initiation and formation of calcium sparks in arterial smooth muscle: comparison with striated muscle |
| Q47259747 | Roles of impaired intracellular calcium cycling in arrhythmogenicity of diabetic mouse model |
| Q28585005 | RyRCa2+ leak limits cardiac Ca2+ window current overcoming the tonic effect of calmodulinin mice |
| Q44923040 | Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats |
| Q43229407 | Targeted GLUT-4 deficiency in the heart induces cardiomyocyte hypertrophy and impaired contractility linked with Ca(2+) and proton flux dysregulation |
| Q91689994 | Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy |
| Q38815425 | The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions |
| Q51389323 | The chronic effects of neonatal alloxan-induced diabetes mellitus on ventricular myocyte shortening and cytosolic Ca2+ |
| Q37215457 | The complexities of diabetic cardiomyopathy: lessons from patients and animal models |
| Q38551638 | The role of CaMKII in diabetic heart dysfunction |
| Q36007199 | The role of Na+/H+ exchanger in Ca2+ overload and ischemic myocardial damage in hearts from type 2 diabetic db/db mice |
| Q47592128 | The role of the endoplasmic reticulum protein calreticulin in mediating TGF-β-stimulated extracellular matrix production in fibrotic disease |
| Q33781282 | There goes the neighborhood: pathological alterations in T-tubule morphology and consequences for cardiomyocyte Ca2+ handling |
| Q89620118 | Unbalance Between Sarcoplasmic Reticulum Ca2 + Uptake and Release: A First Step Toward Ca2 + Triggered Arrhythmias and Cardiac Damage |
| Q35564129 | Updating experimental models of diabetic cardiomyopathy |
| Q48274275 | Voltage dependence of the Ca2+ transient in endocardial and epicardial myocytes from the left ventricle of Goto-Kakizaki type 2 diabetic rats. |